Skip to content

Physical Activity Measured Through Accelerometers and Its Association With Endothelial Function in Young Patients With Fontan Physiology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02938429
Enrollment
25
Registered
2016-10-19
Start date
2016-10-31
Completion date
2020-08-31
Last updated
2022-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Defects

Keywords

congenital

Brief summary

This study will be a cross sectional assessment of physical activity as measured through accelerometers and its association with endothelial function of children with Fontan circulation and healthy age and gender matched controls who are followed at the University of Alberta - Stollery Children's hospital.

Interventions

OTHERPhysical activity measures via Actigraph GT3X+ accelerometers for 7 consecutive days

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Children with Fontan physiology between the ages 24 months to 18 years at the Stollery Children's Hospital 2. Informed written consent obtained prior to enrolment 3. At least 6 months post Fontan procedure

Exclusion criteria

1. Patient hospitalized within the previous 2 weeks 2. Patient unable to ambulate independently 3. Underwent coarctation of the aorta repair using a subclavian flap.

Design outcomes

Primary

MeasureTime frame
Physical activity measured by accelerometersOnce consent/assent is obtained, participants will be asked to wear an Actigraph GT3X+ accelerometers for seven consecutive days, during waking hours.
Endothelial function measured by Digital Thermal Monitoring (DTM) via the automated, operator-independent protocol (VENDYS-6000, Endothelix Inc., Houston, TX) and the Endothelial Pulse Amplitude Test (Endo-PAT, Itamar Medical).Once consent/assent is obtained, endothelial function will be measured one time during a routine clinical visit.

Secondary

MeasureTime frame
Vascular health questionnaireOnce during routine clinical visit after informed consent/assent.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026